Table 5.

Evaluation of a class solution for prostate IMRT: Scores associated with organs at risk (median [range]): comparison of the clinical plan (CP) and class solutions T1, T2 and Tfinal.

Metric	CP	T1	T2	Tfinal	RM-ANOVA (P value)
[RECTUM] Volume (cc) covered by 102.5%TD	0.00 (0.00–0.00)	0.00 (0.00–0.00)	0.00 (−1.13 to 0.00)	0.00 (0.00–0.00)	NSa
[RECTUM] % covered by 40 Gy	10.00 (0.94–10.00)	10.00 (0.10–10.00)	10.00 (0.10–10.00)	10.00 (0.10–10.00)	0.239
[RECTUM] % covered by 65 Gy	10.00 (0.10–10.00)	10.00 (0.10–10.00)	10.00 (0.10–10.00)	10.00 (0.10–10.00)	0.6886
[RECTUM] % covered by 75 Gy	10.00 (3.75–10.00)	10.00 (2.72–10.00)	10.00 (0.100–10.00)	10.00 (2.01–10.00)	0.3182
[BLADDER] % covered by 60 Gy	5.00 (1.74–5.00)	5.00 (0.00–5.00)	5.00 (0.00–5.00)	5.00 (1.14–5.00)	0.9504
[BLADDER] % covered by 40 Gy	5.00 (0.00–5.00)	5.00 (0.00–5.00)	5.00 (0.00–5.00)	5.00 (0.00–5.00)	0.8846
[BULB] % covered by 50 Gy	2.00 (2.00–2.00)	2.00 (2.00–2.00)	2.00 (2.00–2.00)	2.00 (2.00–2.00)	1.0a
[L FEMORAL HEAD] % covered by 45 Gy	2.00 (2.00–2.00)	2.00 (0.85–2.00)	2.00 (2.00–2.00)	2.00 (2.00–2.00)	0.9922
[R FEMORAL HEAD] % covered by 45 Gy	2.00 (2.00–2.00)	2.00 (0.47–2.00)	2.00 (2.00–2.00)	2.00 (2.00–2.00)	0.9922

^aNS, not significant.